The development of biocompatiable efficient photothermal coupling agent (PCA) for image-guided photothermal therapy of cancer has gained increasing interests in recent years. Although various PCAs have been developed, the clinical translations of these materials have been largely hindered by the potential biosafety issues and challenges of scaling-up manufactures. In this research, we proposed nano-sized indocyanine green (ICG) J-aggregate (IJA) as a promising PCA which is fabricated by a very facile method using clinical-approved ICG as the only excipient. The as-prepared IJA remains stable in various solution and shows a ~115 nm red-shift in absorption peak compared to free ICG. Importantly, IJA can be disassociated into free ICG again after internalized into cells and exhibits high biosafety comparable to ICG. The IJA performs well for photothermal therapy both in vitro and in vivo. In addition, the IJA can also be used as a good photoacoustic contrast agent and internalization-responsive fluorescence probe. The facile preparation, high safety and excellent theranostic performance indicated that IJA might be a promising one-component agent for cancer theranostics.
Inflammation
is an immunological response involved in various inflammatory
disorders ranging from neurodegenerative diseases to cancers. Luminol
has been reported to detect myeloperoxidase (MPO) activity in an inflamed
area through a light-emitting reaction. However, this method is limited
by low tissue penetration and poor spatial resolution. Here, we fabricated
a nanobubble (NB) doped with two tandem lipophilic dyes, red-shifting
luminol-emitted blue light to near-infrared region through a process
integrating bioluminescence resonance energy transfer (BRET) and fluorescence
resonance energy transfer (FRET). This BRET–FRET process caused
a 24-fold increase in detectable luminescence emission over luminol
alone in an inflammation model induced by lipopolysaccharide. In addition,
the echogenicity of the BRET–FRET NBs also enables perfused
tissue microvasculature to be delineated by contrast-enhanced ultrasound
imaging with high spatial resolution. Compared with commercially available
ultrasound contrast agent, the BRET–FRET NBs exhibited comparable
contrast-enhancing capability but much smaller size and higher concentration.
This bioluminescence/ultrasound dual-modal contrast agent was then
successfully applied for imaging of an animal model of breast cancer.
Furthermore, biosafety experiments revealed that multi-injection of
luminol and NBs did not induce any observable abnormality. By integrating
the advantages of bioluminescence imaging and ultrasound imaging,
this BRET–FRET system may have the potential to address a critical
need of inflammation imaging.
Patients with pancreatic cancer (PCa) have a poor prognosis apart from the few suitable for surgery. Photodynamic therapy (PDT) is a minimally invasive treatment modality whose efficacy and safety in treating unresectable localized PCa have been corroborated in clinic. Yet, it suffers from certain limitations during clinical exploitation, including insufficient photosensitizers (PSs) delivery, tumor-oxygenation dependency, and treatment escape of aggressive tumors. To overcome these obstacles, an increasing number of researchers are currently on a quest to develop photosensitizer nanoparticles (NPs) by the use of a variety of nanocarrier systems to improve cellular uptake and biodistribution of photosensitizers. Encapsulation of PSs with NPs endows them significantly higher accumulation within PCa tumors due to the increased solubility and stability in blood circulation. A number of approaches have been explored to produce NPs co-delivering multi-agents affording PDT-based synergistic therapies for improved response rates and durability of response after treatment. This review provides an overview of available data regarding the design, methodology, and oncological outcome of the innovative NPs-based PDT of PCa.
Anisotropic modification on nanodiscs could trigger huge differences in their endocytosis mode and following behaviors. In article number https://doi.org/10.1002/adfm.201700406 Zhifei Dai, Qiang Zhang, and co‐workers design analyze the cellular uptake of nanoparticulates differing in anisotropy of shape and ligand modification. This anisotropy‐based approach is promising for manipulating the biointeraction mode of nanomaterials and its outcome.
The integration of diagnostic and therapeutic functionalities into one nanoplatform shows great promise in cancer therapy. In this research, manganese (II) chelate functionalized copper sulfide nanoparticles were successfully prepared using a facile hydrothermal method. The obtained ultrasmall nanoparticles exhibit excellent photothermal effect and photoaoustic activity. Besides, the high loading content of Mn(II) chelates makes the nanoparticles attractive T1 contrast agent in magnetic resonance imaging (MRI). In vivo photoacoustic imaging (PAI) results showed that the nanoparticles could be efficiently accumulated in tumor site in 24 h after systematic administration, which was further validated by MRI tests. The subsequent photothermal therapy of cancer in vivo was achieved without inducing any observed side effects. Therefore, the copper sulfide nanoparticles functionalized with Mn(II) chelate hold great promise as a theranostic nanomedicine for MR/PA dual-modal imaging guided photothermal therapy of cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.